Corrections policy and log

How to request a correction

Email contact@cosmetinutrient.com with the page URL, the exact passage, what appears wrong, and a reliable source when available. Advertising requests and disagreements without checkable evidence do not affect editorial conclusions.

How requests are reviewed

• We first distinguish a factual or source error from a wording preference, an outdated link, or a typographical mistake.
• The cited source and the article's original sources are checked in context, including the tested material, concentration, model, endpoint, formula, and population when relevant.
• A material error is corrected in both language versions when it affects both, and the page review date is updated.
• A change that alters the meaning of a benefit, mechanism, caution, or source interpretation is added to the public log below. Minor spelling, layout, and broken-link fixes are made without a separate log entry.

Public correction log

This public log begins on August 28, 2026. Earlier clarity edits and editorial revisions are reflected in each page's review date and are not reconstructed retroactively here.

The entries below record substantive corrections in both language editions. The September 8 changes were missing from this log; they were added on September 22 after checking the editorial and publication records.

September 8, 2026 — Rose and wheatgrass extracts

• Rose flower extract: removed a retracted paper (PMC11339857) from the evidence sources. The revised discussion identifies the extract fractions and cell-test conditions of the separate 2023 study it cites.
• Wheatgrass extract: corrected the title and summary, which could imply that recovery research on other wheat-derived materials established the same benefit for wheat sprout extract. The revised wording distinguishes the tested materials.

• Rose flower extract
• Wheatgrass extract

September 22, 2026 — Adenosine advice and EGF illustration

• Adenosine: separated general retinol-combination advice from pregnancy precautions. The article now explicitly says to avoid retinoids during pregnancy and does not describe an adenosine product as pregnancy-safe merely because it is not a retinoid.
• EGF: removed an illustration that could imply proven passage through intact skin. The article retains the explanation of growth-factor signalling and the distinction between biological activity and delivery from a cosmetic cream.

• Adenosine
• EGF cream